Plasma metabolomic characterization of pulmonary tuberculosis with type 2 diabetes mellitus during disease progression
Type 2 diabetes mellitus (T2DM) is a major risk factor for pulmonary tuberculosis (PTB); it exacerbates disease severity and reduces the efficacy of anti-tuberculosis therapy. However, systemic metabolic interactions between PTB and T2DM during treatment remain unclear.
Authors
- 何祚宽(Zuokuan He)
Publication Details
- Journal
- China National GeneBank DataBase
- Published
- 2026-11-06
- DOI
- https://doi.org/10.26036/cnp0008986
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00